Filtros de búsqueda

Lista de obras de Dawn Waterhouse

A Low Carbohydrate, High Protein Diet Slows Tumor Growth and Prevents Cancer Initiation

artículo científico publicado en 2011

A novel combination of Chinese medicines to treat advanced cancers and lymphomas in rats

article

A novel liposomal irinotecan formulation with significant anti-tumour activity: use of the divalent cation ionophore A23187 and copper-containing liposomes to improve drug retention.

artículo científico publicado en 2007

Determination of an optimal dosing schedule for combining Irinophore C™ and temozolomide in an orthotopic model of glioblastoma.

artículo científico publicado en 2015

HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization.

artículo científico publicado en 2004

Irinophore C: a liposome formulation of irinotecan with substantially improved therapeutic efficacy against a panel of human xenograft tumors.

artículo científico publicado en 2008

Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities

artículo científico publicado en 2014

Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancer

artículo científico publicado en 2014

Irinophore C™, a lipid-based nanoparticulate formulation of irinotecan, is more effective than free irinotecan when used to treat an orthotopic glioblastoma model.

artículo científico publicado en 2011

Lipid-based nanoformulation of irinotecan: dual mechanism of action allows for combination chemo/angiogenic therapy

scientific article published on 01 November 2011

Liposomal irinotecan: formulation development and therapeutic assessment in murine xenograft models of colorectal cancer.

artículo científico publicado en 2004

Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructs

scientific article published on 05 March 2007

Pharmacodynamic behavior of liposomal antisense oligonucleotides targeting Her-2/neu and vascular endothelial growth factor in an ascitic MDA435/LCC6 human breast cancer model.

artículo científico

Plasma protein binding, lipoprotein distribution and uptake of free and lipid-associated BCL-2 antisense oligodeoxynucleotides (G3139) in human melanoma cells.

artículo científico publicado en 2002

Preparation, Characterization, and Biological Analysis of Liposomal Formulations of Vincristine

article

Retraction. A novel combination of Chinese medicines to treat advanced cancers and lymphomas tested in rats

artículo científico publicado en 2010

Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK).

artículo científico publicado en 2008

Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.

artículo científico publicado en 2011

Temporal targeting in cancer: combined chemotherapy and antiangiogenic therapy

scientific article published on 01 October 2006

The liposomal formulation of doxorubicin

artículo científico publicado en 2005

The role of the transition metal copper and the ionophore A23187 in the development of Irinophore C™

artículo científico publicado en 2010

Topophore C: a liposomal nanoparticle formulation of topotecan for treatment of ovarian cancer ⬇️

artículo científico publicado el 22 de mayo de 2012

Validating the use of a luciferase labeled breast cancer cell line, MDA435LCC6, as a means to monitor tumor progression and to assess the therapeutic activity of an established anticancer drug, docetaxel (Dt) alone or in combination with the ILK inh

artículo científico publicado en 2011

Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine

artículo científico publicado en 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda